15th Jan 2007 15:01
GW Pharmaceuticals PLC15 January 2007 GW Pharmaceuticals plc Notification of Results Porton Down, UK, 15 January 2007: GW Pharmaceuticals plc (AIM: GWP) will beannouncing its preliminary results for the year ended 30 September 2006 onTuesday 30 January 2007. Enquiries: Financial Dynamics 020 7831 3113Gemma Cross Brown Notes to Editors About GW Pharmaceuticals plc GW was founded in 1998 and listed on the AiM, a market of the London StockExchange, in June 2001. Operating under licence from the UK Home Office, theCompany is developing cannabis-derived pharmaceutical products for patients withmultiple sclerosis, neuropathic pain, cancer pain, spinal cord injury,rheumatoid arthritis, and other severe medical conditions. GW has assembled a team of over 100 scientists with extensive experience indeveloping both plant-based prescription pharmaceutical products and medicinescontaining controlled substances. GW is dedicated to developing treatmentoptions that alleviate pain and other neurological symptoms in patients whosuffer from serious ailments. For further information, please visit the Company's website: www.gwpharm.com This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
GWP.L